Biocompatibility of heparin-coated extracorporeal bypass circuits: A randomized, masked clinical trial

INIS

• heparin 100%
• bypasses 100%
• patients 41%
• thrombin 41%
• comparative evaluations 25%
• filters 25%
• values 25%
• administration 16%
• morbidity 16%
• protamines 16%
• blood 16%
• operation 16%
• enzymes 16%
• scanning electron microscopy 8%
• surgery 8%
• clinical trials 8%
• surfaces 8%
• risks 8%
• proteins 8%
• deposition 8%
• units 8%
• populations 8%
• stimulation 8%
• length 8%
• losses 8%
• mortality 8%
• plasma 8%
• doses 8%
• valves 8%
• granulocytes 8%
• coronaries 8%
• arteries 8%
• oxygen 8%
• ventilation 8%
• control systems 8%
• removal 8%
• transfusions 8%

Medicine and Dentistry

• Heparin 100%
• Cardiopulmonary Bypass 75%
• Thrombin 41%
• Thrombocyte Activation 25%
• Biocompatibility 25%
• Morbidity 16%
• Surgery 16%
• Enzyme Linked Immunosorbent Assay 16%
• Bleeding 16%
• Protamine 16%
• Leukocyte Activation 16%
• PADGEM Protein 16%
• Patient 16%
• Inpatient 16%
• Oxygen 8%
• Scanning Electron Microscopy 8%
• Patient Population 8%
• Platelet 8%
• Stimulation 8%
• Qualitative Analysis 8%
• Blood Proteins 8%
• Heart Surgery 8%
• Antithrombotic 8%
• Flow Cytometry 8%
• Coronary Artery Bypass Graft 8%
• Extubation 8%
• Granulocyte 8%
• Bypass 8%
• Thrombocytopoiesis 8%
• Blood Transfusion 8%
• Postoperative Hemorrhage 8%
• Antithrombin III 8%
• Mortality 8%
• 4 Chloro 3',6' Dimethyl 2,2' Iminodibenzoic Acid 8%
• Extracorporeal Circulation 8%
• Quantitative Analysis 8%
• Clinical Trial 8%
• Marker 8%
• Intensive Care Unit 8%
• Syndrome 8%